vs
Side-by-side financial comparison of JBG SMITH Properties (JBGS) and Nutex Health, Inc. (NUTX). Click either name above to swap in a different company.
Nutex Health, Inc. is the larger business by last-quarter revenue ($151.7M vs $127.6M, roughly 1.2× JBG SMITH Properties). Nutex Health, Inc. runs the higher net margin — 7.8% vs -35.7%, a 43.5% gap on every dollar of revenue. On growth, JBG SMITH Properties posted the faster year-over-year revenue change (-2.5% vs -41.1%). Over the past eight quarters, Nutex Health, Inc.'s revenue compounded faster (50.0% CAGR vs -6.3%).
JBG SMITH PropertiesJBGSEarnings & Financial Report
JBG SMITH Properties is a publicly traded real estate investment trust based in Bethesda, Maryland.
Nutex Health Inc. is an American for-profit health care company and operator of healthcare facilities headquartered in Houston, Texas.
JBGS vs NUTX — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $127.6M | $151.7M |
| Net Profit | $-45.5M | $11.8M |
| Gross Margin | — | 30.4% |
| Operating Margin | -47.5% | 20.4% |
| Net Margin | -35.7% | 7.8% |
| Revenue YoY | -2.5% | -41.1% |
| Net Profit YoY | 24.0% | -80.8% |
| EPS (diluted) | $-0.76 | $2.34 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $127.6M | $151.7M | ||
| Q3 25 | $123.9M | $267.8M | ||
| Q2 25 | $126.5M | $244.0M | ||
| Q1 25 | $120.7M | $211.8M | ||
| Q4 24 | $130.8M | $257.6M | ||
| Q3 24 | $136.0M | $78.8M | ||
| Q2 24 | $135.3M | $76.1M | ||
| Q1 24 | $145.2M | $67.5M |
| Q4 25 | $-45.5M | $11.8M | ||
| Q3 25 | $-28.6M | $55.4M | ||
| Q2 25 | $-19.2M | $-17.7M | ||
| Q1 25 | $-45.7M | $21.2M | ||
| Q4 24 | $-59.9M | $61.6M | ||
| Q3 24 | $-27.0M | $-8.8M | ||
| Q2 24 | $-24.4M | $-364.0K | ||
| Q1 24 | $-32.3M | $-364.0K |
| Q4 25 | — | 30.4% | ||
| Q3 25 | — | 57.8% | ||
| Q2 25 | — | 51.2% | ||
| Q1 25 | — | 55.9% | ||
| Q4 24 | — | 55.0% | ||
| Q3 24 | — | 27.8% | ||
| Q2 24 | — | 29.7% | ||
| Q1 24 | — | 15.1% |
| Q4 25 | -47.5% | 20.4% | ||
| Q3 25 | -27.5% | 48.7% | ||
| Q2 25 | -18.4% | 13.8% | ||
| Q1 25 | -44.7% | 38.1% | ||
| Q4 24 | -53.6% | 44.4% | ||
| Q3 24 | -22.4% | 12.3% | ||
| Q2 24 | -24.3% | 7.0% | ||
| Q1 24 | -30.1% | 2.1% |
| Q4 25 | -35.7% | 7.8% | ||
| Q3 25 | -23.1% | 20.7% | ||
| Q2 25 | -15.2% | -7.3% | ||
| Q1 25 | -37.9% | 10.0% | ||
| Q4 24 | -45.8% | 23.9% | ||
| Q3 24 | -19.8% | -11.2% | ||
| Q2 24 | -18.0% | -0.5% | ||
| Q1 24 | -22.2% | -0.5% |
| Q4 25 | $-0.76 | $2.34 | ||
| Q3 25 | $-0.48 | $7.76 | ||
| Q2 25 | $-0.29 | $-2.95 | ||
| Q1 25 | $-0.56 | $3.33 | ||
| Q4 24 | $-0.70 | $11.56 | ||
| Q3 24 | $-0.32 | $-1.72 | ||
| Q2 24 | $-0.27 | $-0.07 | ||
| Q1 24 | $-0.36 | $-0.08 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $75.3M | $185.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.2B | $329.4M |
| Total Assets | $4.4B | $918.5M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $75.3M | $185.6M | ||
| Q3 25 | $64.4M | $166.0M | ||
| Q2 25 | $61.4M | $96.7M | ||
| Q1 25 | $81.3M | $84.7M | ||
| Q4 24 | $145.8M | $40.6M | ||
| Q3 24 | $137.0M | $46.9M | ||
| Q2 24 | $163.5M | $40.8M | ||
| Q1 24 | $220.5M | $30.0M |
| Q4 25 | $1.2B | $329.4M | ||
| Q3 25 | $1.2B | $317.2M | ||
| Q2 25 | $1.3B | $235.3M | ||
| Q1 25 | $1.6B | $176.9M | ||
| Q4 24 | $1.8B | $132.4M | ||
| Q3 24 | $1.9B | $60.4M | ||
| Q2 24 | $2.0B | $62.7M | ||
| Q1 24 | $2.1B | $63.0M |
| Q4 25 | $4.4B | $918.5M | ||
| Q3 25 | $4.4B | $964.5M | ||
| Q2 25 | $4.5B | $841.0M | ||
| Q1 25 | $4.7B | $761.9M | ||
| Q4 24 | $5.0B | $655.3M | ||
| Q3 24 | $5.2B | $438.5M | ||
| Q2 24 | $5.3B | $422.4M | ||
| Q1 24 | $5.4B | $404.3M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $73.3M | $70.4M |
| Free Cash FlowOCF − Capex | — | $69.0M |
| FCF MarginFCF / Revenue | — | 45.5% |
| Capex IntensityCapex / Revenue | — | 0.9% |
| Cash ConversionOCF / Net Profit | — | 5.95× |
| TTM Free Cash FlowTrailing 4 quarters | — | $245.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $73.3M | $70.4M | ||
| Q3 25 | $8.9M | $99.5M | ||
| Q2 25 | $18.8M | $27.3M | ||
| Q1 25 | $12.9M | $51.0M | ||
| Q4 24 | $129.4M | $54.0K | ||
| Q3 24 | $26.4M | $6.8M | ||
| Q2 24 | $23.8M | $13.3M | ||
| Q1 24 | $37.0M | $3.1M |
| Q4 25 | — | $69.0M | ||
| Q3 25 | — | $99.2M | ||
| Q2 25 | — | $26.5M | ||
| Q1 25 | — | $50.9M | ||
| Q4 24 | — | $-341.0K | ||
| Q3 24 | — | $6.2M | ||
| Q2 24 | — | $12.7M | ||
| Q1 24 | — | $2.3M |
| Q4 25 | — | 45.5% | ||
| Q3 25 | — | 37.0% | ||
| Q2 25 | — | 10.9% | ||
| Q1 25 | — | 24.0% | ||
| Q4 24 | — | -0.1% | ||
| Q3 24 | — | 7.8% | ||
| Q2 24 | — | 16.7% | ||
| Q1 24 | — | 3.4% |
| Q4 25 | — | 0.9% | ||
| Q3 25 | — | 0.1% | ||
| Q2 25 | — | 0.3% | ||
| Q1 25 | — | 0.0% | ||
| Q4 24 | — | 0.2% | ||
| Q3 24 | — | 0.8% | ||
| Q2 24 | — | 0.7% | ||
| Q1 24 | — | 1.1% |
| Q4 25 | — | 5.95× | ||
| Q3 25 | — | 1.80× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 2.40× | ||
| Q4 24 | — | 0.00× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
JBGS
Segment breakdown not available.
NUTX
| Hospital Division | $143.7M | 95% |
| Population Health Management Division | $8.0M | 5% |
